Moreover, fifty two out of 133 (39.1%) BMSCC patients showed ratio of less than 0 (CTAN/Tumor tissues) of cleaved caspase-3 expression since missing value ratio (because the cutoff values was 0 for cleaved caspase-3) were eighty out of 133 (60.2%) in BMSCC patients. This evidence concerns the gene CASP3 and neoplasm.